ChemoSensoryX Biosciences SA > Company

Company

Company profile: smart biotech for odor management

ChemoSensoryX Biosciences SA is the leading discovery company for products and services related to chemical communications mediated by human olfactory and taste receptors. ChemoSensoryX Biosciences SA offers a unique, patented technological platform based on an exclusive worldwide license acquired from Duke University. Its offices are located in Brussels on the Erasme Medical Campus (ULB) where it currently employs 13 people. The findings have been gathered in a database that enables the Company to reproduce an artificial nose that expresses the whole repertoire of human Olfactory Receptors (hORs). The applications of ChemoSensoryX’s research allow for the development of new products and technologies for consumer needs in the area of flavors & fragrances, but also all industries that deal with odor or taste issues. The applications of ChemoSensoryX’s research leads the development of new products and technologies for consumer needs in multiple areas. In the Flavor and Fragrance industry, the company’s main area of focus, ChemoSensoryX’s platform and product portfolios represent an innovative approach with successful solutions for:

                                                                                                                                                        • Malodor counteraction

                                                                                                                                                                                                                                                                                                                                                                                          • Development of new fragrance materials

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            • Creation of cost-effective formulations

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Thanks to the therapeutic characteristics of GPCRs, ChemoSensoryX’s research can also be leveraged in pharmaceutical markets (Drug Discovery: oncology, immunology, etc).